Cockroft Bettina M. has filed 5 insider transactions across 2 companies since April 2024.
Most recent transaction: a grant/award of 1517 shares of CNS Pharmaceuticals, Inc. ($CNSP) on November 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2025 | CNS Pharmaceuticals, Inc. | $CNSP | Cockroft Bettina M. | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| June 5, 2025 | Annexon, Inc. | $ANNX | Cockroft Bettina M. | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2024 | Annexon, Inc. | $ANNX | Cockroft Bettina M. | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Cockroft Bettina M. | Director | A | Option to purchase common stock | 17500 | $0.00 | 35,574.0000 | 0 | 96.82% | 0.00% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Cockroft Bettina M. | Director | A | Restricted Stock Units | 17500 | $0.00 | 53,074.0000 | 0 | 49.19% | 0.00% |